La Canada Ventures, Inc. – Trademark Portfolio
Entity Type: 03
La Canada Ventures, Inc. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 15 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include MD, MD 101, MD FACTOR, MD LASH FACTOR, and MD INTIMATE FRESH. The owner is based in San Mateo, CA.
448 N. San Mateo Dr.,
San Mateo, CA 94401
Showing of trademarks Trademarks
Trademark Classifications
La Canada Ventures, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does La Canada Ventures, Inc. have?
La Canada Ventures, Inc. has 16 U.S. trademarks filed with the USPTO. Of these, 10 registered, 5 abandoned, 1 cancelled.
What trademark classes does La Canada Ventures, Inc. file in?
La Canada Ventures, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are La Canada Ventures, Inc.'s most well-known trademarks?
La Canada Ventures, Inc.'s registered trademark portfolio includes well-known marks such as MD, MD 101, MD FACTOR, MD LASH FACTOR, and MD INTIMATE FRESH. These are among 10 currently registered trademarks in the portfolio.
What is La Canada Ventures, Inc.'s trademark registration success rate?
La Canada Ventures, Inc. has a 63% trademark registration rate, with 10 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.